Arkolith/Insider Trading/EWTX/Form 4

Carruthers R Michael

Chief Financial OfficerEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed Aug 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2025Option exercise(M)6K—$088K
Aug 12, 2025Sell(S)1K$13.39$19K86K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2025Grant(A)27K—$027K
Aug 12, 2025Option exercise(M)6K—$017K
Aug 12, 2025Grant(A)161K—$0161K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-005797) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML